CNTN — Canton Strategic Holdings Share News
0.000.00%
Last trade - 00:00- $148.21m
- $110.97m
Brief: Hillstream Enters Exclusive Option Agreement To Buy Clinical Stage Asset For Chronic Pruritis
Brief: Hillstream Advances Next-Gen Multispecific Antibodies For Solid Tumors
Brief: Hillstream Biopharma Announces Strategic Reprioritization Of Pipeline To Targeting Her2/Her3 Solid Tumors
Brief: Hillstream BioPharma Licenses Technology To Develop Proprietary HER2 and HER3 Antibody Drug Conjugates Against Drug-Resistant Breast, Lung, Gastric, And Ovarian Cancers
Brief: Hillstream Biopharma Gets Nasdaq Notice On Non-Compliance With $1 Minimum Bid Price Requirement
Brief: Hillstream Biopharma On May 17 Concluded That Co's Accounting For Recording Certain Financed Insurance Policies Was Considered Incorrect
Brief: Hillstream Biopharma Inc - On May 9, 2023, Board Of Co Increased Size Of The Board To Five Members
Brief: Hillstream Biopharma Announces Closing Of Public Offering Of Common Stock
U.S. STOCKS ON THE MOVE-First Republic, Charter Communications, FirstEnergy
U.S. STOCKS ON THE MOVE-Hillstream BioPharma, First Republic, Pinterest
Hillstream BioPharma plunges on deep-discounted equity offering
Brief: Hillstream Biopharma Announces Pricing Of Public Offering
Brief: Hillstream BioPharma Announces Proposed Public Offering
Brief: Hillstream Biopharma Selects Oncobay Clinical To Advance Clinical And Regulatory Development For Its Lead Drug Candidate Hsb-1216, An Anti-Cancer Mechanism
Brief: Hillstream Biopharma Announces Pharmacokinetic Data Of Hsb-1216 Supportive Of Development Strategy And Pre-Clinical Data
Brief: Hillstream Biopharma Regains Compliance With Nasdaq Listing Minimum Bid Price Rule
U.S. STOCKS ON THE MOVE-Ralph Lauren, Howmet, Insulet
U.S. STOCKS ON THE MOVE-Top Ships, Brightcove, Airbnb
Hillstream BioPharma rises on cancer technology licensing